Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8313763 Sustained delivery formulations of rapamycin compounds

Patent 8313763 was granted and assigned to Tolmar on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Tolmar

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83137630

Patent Inventor Names

Christopher M. Lindemann0

Eric Dadey0

Philippe Maria Clotaire Margaron0

Ruihong Li0

Date of Patent

November 20, 2012

Patent Application Number

117065690

Date Filed

February 15, 2007

Patent Citations Received

‌

US Patent 12090136 Apparatus for treating Benign Prostatic Hyperplasia

‌

US Patent 11779553 Methods and devices for treatment of eyelid ptosis

‌

US Patent 11839611 Buprenorphine dosing regimens

‌

US Patent 11911499 System and method for prostate treatment

‌

US Patent 11951098 Therapeutic agent for meibomian dysfunction

‌

US Patent 11957654 Treating benign prostatic hyperplasia

‌

US Patent 11974979 Treatments for benign prostatic hyperplasia

Patent Primary Examiner

‌

Paul Dickinson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8313763 Sustained delivery formulations of rapamycin compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API